CD163 and neoplasm: The fast growing locally aggressive and metastatic MatLyLu tumors appear to be particularly effective in recruiting macrophages, of which many are of the tumor-stimulating M2 phenotype (CD163 positive), to the tumor, to the invasive front and to the surrounding tumor-bearing organ.